Cardiovascular risk factor control among diabetic patients attending community-based diabetic care clinics in Italy
- 1 February 2007
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 75 (2) , 176-183
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialThe Lancet, 2004
- European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)European Journal of Preventive Cardiology, 2003
- MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialThe Lancet, 2003
- Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational studyBMJ, 2000
- Coronary Heart Disease in Patients with DiabetesNew England Journal of Medicine, 2000
- Reduced Coronary Events in Simvastatin-Treated Patients With Coronary Heart Disease and Diabetes or Impaired Fasting Glucose LevelsArchives of internal medicine (1960), 1999
- Diabetes and Cardiovascular DiseaseCirculation, 1999
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart ProgramDiabetes Care, 1996